Company intelligence / Profile preview

Digital China Health Technologies Co., Ltd.

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

DHC operates commercial platforms for medical big data, AI-assisted diagnosis, and clinical research. The company has deployed multiple hospital-wide integrated platforms and participates in national precision medicine initiatives.

Therapeutic areas: NephrologyImmunologyCardiovascularRare DiseasesOncology
Industry: Digital Health Medical Devices

Partnerships

PhilipsSK GroupTencentIQVIANanfang Hospital (Southern Medical University)National Cancer CentrePublic Health EnglandHarvard-MIT Broad InstituteShanghai Jiaotong University (Bio-X)China Cardiovascular Consortium

Beyond the preview

Go deeper on Digital China Health Technologies Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digital China Health Technologies Co., Ltd..

Explore the full profile